RVL Pharmaceuticals plc (RVLPQ)
USD 0.0
(900.0%)
USD 0.0
(900.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | -51.69 Million USD | 20.38% |
| 2021 | -64.92 Million USD | 18.43% |
| 2020 | -79.58 Million USD | 70.62% |
| 2019 | -270.9 Million USD | -146.99% |
| 2018 | -109.68 Million USD | -166.59% |
| 2017 | -41.14 Million USD | 1.62% |
| 2016 | -41.82 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q1 | -11.61 Million USD | 36.61% |
| 2023 Q2 | -23.88 Million USD | -105.73% |
| 2022 Q4 | -18.31 Million USD | -26.81% |
| 2022 Q2 | -12.1 Million USD | -77.48% |
| 2022 FY | -51.69 Million USD | 20.38% |
| 2022 Q1 | -6.82 Million USD | 64.86% |
| 2022 Q3 | -14.44 Million USD | -19.33% |
| 2021 Q3 | -22.23 Million USD | 0.0% |
| 2021 FY | -64.92 Million USD | 18.43% |
| 2021 Q4 | -19.41 Million USD | 12.69% |
| 2020 FY | -79.58 Million USD | 70.62% |
| 2019 FY | -270.9 Million USD | -146.99% |
| 2018 FY | -109.68 Million USD | -166.59% |
| 2017 FY | -41.14 Million USD | 1.62% |
| 2016 FY | -41.82 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | -3770.81% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -640.272% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 197.571% |
| Nascent Biotech, Inc. | -2.08 Million USD | -2376.048% |
| Rebus Holdings, Inc. | -1.02 Million USD | -4967.843% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 179.364% |
| Qrons Inc. | -789.34 Thousand USD | -6448.704% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -8073.85% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 17.424% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -12341.543% |
| Skye Bioscience, Inc. | -37.64 Million USD | -37.315% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 31.043% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -686.057% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -18806.958% |
| SQZ Biotechnologies Company | -79.46 Million USD | 34.949% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -1687.17% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -2739.396% |
| Mesoblast Limited | -87.95 Million USD | 41.23% |
| Marizyme, Inc. | -65.34 Million USD | 20.896% |
| Genus plc | 7.9 Million USD | 754.329% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -374.598% |
| Pharming Group N.V. | -10.54 Million USD | -390.064% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -2282.324% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -1293.227% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -484.487% |
| ContraFect Corporation | -65.15 Million USD | 20.661% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -957.948% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -2892.379% |
| IMV Inc. | -36.48 Million USD | -41.677% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -541.365% |
| MultiCell Technologies, Inc. | -380.07 USD | -13600552.511% |
| ONE Bio Corp. | 8.67 Million USD | 695.762% |
| Accustem Sciences Inc. | -3.74 Million USD | -1279.771% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -3979.442% |
| Q BioMed Inc. | -2.05 Million USD | -2418.989% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -1284.731% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -2071.139% |
| Biomind Labs Inc. | -1.21 Million USD | -4156.872% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 13.451% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -1566.533% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -554.073% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -2551.893% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -345065.598% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -225.692% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -788.598% |
| GB Sciences, Inc. | -1.36 Million USD | -3696.201% |
| Alpha Cognition Inc. | -13.77 Million USD | -275.326% |
| HST Global, Inc. | -146.21 Thousand USD | -35254.627% |
| CSL Limited | 2.64 Billion USD | 101.957% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -2845.797% |
| Halberd Corporation | -79.67 Thousand USD | -64777.755% |
| Enzolytics Inc. | -2.17 Million USD | -2274.644% |
| Agentix Corp. | -1.37 Million USD | -3661.577% |
| Resverlogix Corp. | -3.61 Million USD | -1331.911% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -1529.924% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 82.48% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 52846.939% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 846.499% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -1201.085% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -1608.186% |
| AVAX Technologies, Inc. | -6.41 Million USD | -705.969% |
| Zenith Capital Corp. | -10.59 Million USD | -387.844% |
| Genscript Biotech Corporation | -95.47 Million USD | 45.859% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -222307.71% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -1146.811% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -85425.278% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -2478.007% |
| Kadimastem Ltd | -3.3 Million USD | -1462.92% |
| Helix BioMedix, Inc. | -1.05 Million USD | -4794.812% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -1253.548% |
| BioStem Technologies, Inc. | -8.48 Million USD | -509.361% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -11611.742% |
| LadRx Corporation | 400.44 Thousand USD | 13008.704% |
| Cell Source, Inc. | -5.32 Million USD | -871.433% |
| Regen BioPharma, Inc. | 1.02 Million USD | 5150.473% |
| Regen BioPharma, Inc. | 1.02 Million USD | 5150.473% |
| NovAccess Global Inc. | -4.76 Million USD | -983.874% |
| Affymax, Inc. | -14.42 Million USD | -258.375% |
| Itoco Inc. | -1.86 Million USD | -2665.764% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -1063.57% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -2997.184% |
| Mobile Lads Corp. | -2.26 Million USD | -2183.93% |
| CytoDyn Inc. | -49.84 Million USD | -3.714% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -65305.59% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -22559.308% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -5390.219% |
| SYBLEU INC | -180.3 Thousand USD | -28569.358% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -3105.234% |
| International Stem Cell Corporation | -131 Thousand USD | -39359.542% |
| Bioxytran, Inc. | -4.28 Million USD | -1107.756% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -95146.167% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -1942.963% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | -7.53% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -2345.222% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -6519.652% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -1531.692% |
| Neutra Corp. | -233.46 Thousand USD | -22041.22% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -154.753% |
| PureTech Health plc | -65.69 Million USD | 21.318% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | -143.067% |
| IXICO plc | -1.17 Million USD | -4288.115% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -420.721% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 9.515% |
| CSL Limited | 2.64 Billion USD | 101.957% |
| Cellectis S.A. | -103.17 Million USD | 49.898% |